Agenus (Formerly known as Antigenics Inc. - New York)

108 articles about Agenus (Formerly known as Antigenics Inc. - New York)

• First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics Inc. (New York)'s Oncophage Cancer Vaccine in Glioma

  10/10/2007

• Antigenics Inc. (New York) to Present at UBS Warburg Global Life Sciences Conference

  9/20/2007

• Antigenics Inc. (New York) Completes $5 Million in Financing

  9/10/2007

• Antigenics Inc. (New York) Agrees to Sell Up to $20.25 Million in Common Shares

  9/6/2007

• Antigenics Inc. (New York) Reports Second Quarter 2007 Financial Results

  8/2/2007

• Antigenics Inc. (New York) Provides Update on Filing for Approval of Oncophage(R) in Russia for the Treatment of Intermediate-Risk Kidney Cancer

  8/2/2007

• Antigenics Inc. (New York) to Report Second Quarter 2007 Financial Results on August 2, 2007; Conference Call to Follow

  7/26/2007

• John Hatsopoulos Joins Antigenics Inc. (New York)' Board of Directors

  6/11/2007

• Antigenics Inc. (New York)'s QS-21 Stimulon(R) Adjuvant Enters Phase 3 Clinical Trial of GlaxoSmithKline's Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer

  6/5/2007

• Antigenics Inc. (New York) to Webcast 2007 Annual Shareholders Meeting

  5/23/2007

• Antigenics Inc. (New York)'s Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer

  5/21/2007

• Antigenics Inc. (New York) Reports First Quarter 2007 Financial Results

  5/8/2007

• Antigenics Inc. (New York) to Present at UBS Warburg Global Generic and Specialty Pharmaceuticals Conference

  5/2/2007

• Antigenics Inc. (New York) to Report First Quarter 2007 Financial Results on May 8, 2007; Conference Call to Follow

  5/1/2007

• Antigenics Inc. (New York) Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting

  4/16/2007

• Brian Corvese Joins Antigenics Inc. (New York)'s Board of Directors

  3/14/2007

• Antigenics Inc. (New York) to Present at Cowen & Company's Annual Health Care Conference

  3/7/2007

• Antigenics Inc. (New York) Reports Fourth Quarter And Year-End 2006 Financial Results

  2/21/2007

• Antigenics Inc. (New York) To Report Fourth Quarter And Year-End 2006 Financial Results On February 21, 2007; Conference Call To Follow

  2/14/2007

• Peter ThorntonAnd Timothy R. Wright Join Antigenics Inc. (New York)'s Board Of Directors

  12/13/2006